Safety and Efficacy of Canagliflozin in Advanced CKD

Conditions:   ESRD;   CKD Stage 4;   CKD Stage 5 Intervention:   Drug: Invokana 300 mg and 100 mg tablet Sponsor:   McGill University Health Centre/Research Institute of the McGill University Health Centre Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials